客户发表文献

论文在线提交

至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

开始时间
页码: 11/600 每页显示数量
In Vitro and Ex Planta Gold-Bonded and Gold-Mineralized Tobacco Mosaic Virus
Authors: Yifeng Ma, Zhuohong Wu, Nicole F Steinmetz
Journal: Langmuir
PubMed ID: 37540623
Doi: 10.1021/acs.langmuir.3c00688
Products & Services: Peptide Synthesis   
Novel tripeptide RKH derived from Akkermansia muciniphila protects against lethal sepsis
Authors: Shihao Xie , Jiaxin Li , Fengyuan Lyu , Qingming Xiong , Peng Gu , Yuqi Chen , Meiling Chen , Jingna Bao , Xianglong Zhang , Rongjuan Wei , Youpeng Deng , Hongzheng Wang , Zhenhua Zeng , Zhongqing Chen , Yongqiang Deng , Zhuoshi Lian , Jie Zhao , Wei Gong , Ye Chen , Ke-Xuan Liu , Yi Duan , Yong Jiang , Hong-Wei Zhou , Peng Chen
Journal: Gut .
PubMed ID: 37553229
Doi: 10.1136/gutjnl-2023-329996
Products & Services: Peptide Synthesis   
The SlWRKY6-SlPROPEP-SlPep module confers tomato resistance to Phytophthora infestans
Authors: Ruirui Yang , Jie Liu , Zhicheng Wang , Lei Zhao , Tingting Xue , Jun Meng , Yushi Luan
Journal: Scientia Horticulturae
Doi: 10.1016/j.scienta.2023.112117
Products & Services: Peptide Synthesis   
Structural basis for cross-group recognition of an influenza virus hemagglutinin antibody that targets postfusion stabilized epitope
Authors: Keisuke Tonouchi, Yu Adachi, Tateki Suzuki, Daisuke Kuroda, Ayae Nishiyama, Kohei Yumoto, Haruko Takeyama, Tadaki Suzuki, Takao Hashiguchi, Yoshimasa Takahashi
Journal: PLoS Pathog
PubMed ID: 37556494
Doi: 10.1371/journal.ppat.1011554
Products & Services: Peptide Synthesis   
Precision Genome Engineering in Based on a Broad-Host-Range Vector and CRISPR-Cas9 Technology
Authors: Alex Gussak, Maria Laura Ferrando, Mels Schrama, Peter van Baarlen, Jerry Mark Wells
Journal: ACS Synth Biol
PubMed ID: 37602730
Doi: 10.1021/acssynbio.3c00110
Products & Services: Peptide Synthesis   
ABBV-184: A Novel Survivin-specific TCR/CD3 Bispecific T-cell Engager is Active against Both Solid Tumor and Hematologic Malignancies
Authors: Adam S Chervin, Jennifer D Stone, Iwona Konieczna, Kelly M Calabrese, Ningyan Wang, Dipica Haribhai, Feng Dong, Michael K White, Luis E Rodriguez, Gail T Bukofzer, Paul A Ellis, Cormac Cosgrove, Claudie Hecquet, Jerry D Clarin, Joann P Palma, Edward B Reilly
Journal: Mol Cancer Ther
PubMed ID: 37294945
Doi: 10.1158/1535-7163.MCT-22-0770
Products & Services: Peptide Synthesis   
The brassinosteroid-responsive protein OCTOPUS is a novel regulator of immune signaling
Authors: Kaitlyn N Greenwood, Courtney L King, Isabella Melena, Katherine A Stegemann, Maura Donnelly, Anna Childers, Raegan Mozal, Carina A Collins, Benjamin J Spears
Journal: Plant Direct
PubMed ID: 37638229
Doi: 10.1002/pld3.524
Products & Services: Peptide Synthesis   
Crystal structures of MHC class I complexes reveal the elusive intermediate conformations explored during peptide editing
Authors: Lenong Li, Xubiao Peng, Mansoor Batliwala, Marlene Bouvier
Journal: Nat Commun
PubMed ID: 37596268
Doi: 10.1038/s41467-023-40736-6
Products & Services: Peptide Synthesis   
Variation in microbial feature perception in the Rutaceae family with immune receptor conservation in citrus
Authors: Jessica Trinh, Tianrun Li, Jessica Y Franco, Tania Y Toruño, Danielle M Stevens, Shree P Thapa, Justin Wong, Rebeca Pineda, Emmanuel Ávila de Dios, Tracy L Kahn, Danelle K Seymour, Chandrika Ramadugu, Gitta L Coaker
Journal: Plant Physiol
PubMed ID: 37144828
Doi: 10.1093/plphys/kiad263
Products & Services: Peptide Synthesis   
TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal Carcinoma
Authors: Niranjana Amin, Herui Wang, Qi Song, Manju Bhaskar, Sharda Prasad Yadav, Mark R Gilbert, Harish Pant, Emeline Tabouret, Zhengping Zhuang
Journal: Int J Mol Sci
PubMed ID: 37511490
Doi: 10.3390/ijms241411733
Products & Services: Peptide Synthesis   
< 6 7 8 9 10 11 12 13 14 15 16 > Total Pages 600

喜欢新升级的网站吗?

讨厌

不喜欢

一般

喜欢

非常喜欢

*